Myeloproliferative Neoplasms (Hardcover)

Published by Springer, 2012
ISBN 10: 3642249884 / ISBN 13: 9783642249884
New / Hardcover / Quantity Available: 0
From Grand Eagle Retail (Wilmington, DE, U.S.A.)
Available From More Booksellers
View all  copies of this book

About the Book

We're sorry; this specific copy is no longer available. AbeBooks has millions of books. We've listed similar copies below.

Description:

Hardcover. This book focuses on three of the main categories of myeloproliferative neoplasm: polycythemia vera, essential thrombocythemia, and primary myelofibrosis. Relevant laboratory and clinical .Shipping may be from multiple locations in the US or from the UK, depending on stock availability. 240 pages. 0.654. Bookseller Inventory # 9783642249884

About this title:

Synopsis:

This book focuses on three of the main categories of myeloproliferative neoplasm: polycythemia vera, essential thrombocythemia, and primary myelofibrosis. Relevant laboratory and clinical advances are comprehensively covered, and great emphasis is placed on the practical issues that challenge physicians in their daily practice. The main topics considered thus include contemporary diagnostic  approaches, the value and limitations of mutation screening for diagnostic and  prognostic purposes, risk stratification in terms of both survival and other  disease complications such as leukemic transformation and thrombosis, and  modern therapeutic strategies, including conventional drugs, allogeneic stem cell  transplantation, and experimental drugs still under study. The reader will find Critical Concepts and Management Recommendations in Myeloproliferative Neoplasms to be an invaluable and up-to-date source of information from leading authorities in the field.

From the Back Cover:

Myeloproliferative neoplasms (MPNs) are clonal stem cell diseases that, under the World Health Organization classification, are subcategorized into eight clinicopathologic entities. The current book focuses on three of these categories: polycythemia vera, essential thrombocythemia, and primary myelofibrosis. A number of important questions regarding the diagnosis, prognosis, and treatment of these diseases have arisen following the discovery of the JAK2 V617F mutation in the majority of patients with bcr/abl-negative MPNs.

 

This book comprises evidence-based reviews and expert consensus results. It offers comprehensive coverage of relevant laboratory and clinical advances and places great emphasis on the practical issues that challenge physicians in their daily practice. The main topics considered thus include contemporary diagnostic  approaches, the value and limitations of mutation screening for diagnostic and  prognostic purposes, risk stratification in terms of both survival and other  disease complications such as leukemic transformation and thrombosis, and  modern therapeutic strategies, including conventional drugs, allogeneic stem cell  transplantation, and experimental drugs still under study. The reader will find Critical Concepts and Management Recommendations in Myeloproliferative Neoplasms to be an invaluable and up-to-date source of information from leading authorities in the field.

"About this title" may belong to another edition of this title.

Bibliographic Details

Title: Myeloproliferative Neoplasms (Hardcover)
Publisher: Springer
Publication Date: 2012
Binding: Hardcover
Book Condition: New

Top Search Results from the AbeBooks Marketplace

1.

Tiziano Barbui (editor), Ayalew Tefferi (editor)
Published by Springer Berlin Heidelberg 2012-02-03, Berlin |London (2012)
ISBN 10: 3642249884 ISBN 13: 9783642249884
New Hardcover Quantity Available: 5
Seller:
Blackwell's
(Oxford, OX, United Kingdom)
Rating
[?]

Book Description Springer Berlin Heidelberg 2012-02-03, Berlin |London, 2012. hardback. Condition: New. Seller Inventory # 9783642249884

More information about this seller | Contact this seller

Buy New
US$ 189.32
Convert currency

Add to Basket

Shipping: US$ 11.32
From United Kingdom to U.S.A.
Destination, rates & speeds

2.

Published by Springer 2012-02-03 (2012)
ISBN 10: 3642249884 ISBN 13: 9783642249884
New Hardcover Quantity Available: 3
Seller:
Chiron Media
(Wallingford, United Kingdom)
Rating
[?]

Book Description Springer 2012-02-03, 2012. Hardcover. Condition: New. Seller Inventory # NU-LBR-01039326

More information about this seller | Contact this seller

Buy New
US$ 188.89
Convert currency

Add to Basket

Shipping: US$ 37.77
From United Kingdom to U.S.A.
Destination, rates & speeds

3.

Tiziano Barbui (Editor), Ayalew Tefferi (Editor)
Published by Springer (2012)
ISBN 10: 3642249884 ISBN 13: 9783642249884
New Hardcover Quantity Available: 1
Seller:
Ergodebooks
(RICHMOND, TX, U.S.A.)
Rating
[?]

Book Description Springer, 2012. Hardcover. Condition: New. 2012. Seller Inventory # DADAX3642249884

More information about this seller | Contact this seller

Buy New
US$ 195.19
Convert currency

Add to Basket

Shipping: US$ 3.99
Within U.S.A.
Destination, rates & speeds

4.

Tiziano Barbui
Published by Springer-Verlag Gmbh Feb 2012 (2012)
ISBN 10: 3642249884 ISBN 13: 9783642249884
New Quantity Available: 1
Seller:
AHA-BUCH GmbH
(Einbeck, Germany)
Rating
[?]

Book Description Springer-Verlag Gmbh Feb 2012, 2012. Buch. Condition: Neu. Neuware - Myeloproliferative neoplasms (MPNs) are clonal stem cell diseases that, under the World Health Organization classification, are subcategorized into eight clinicopathologic entities. The current book focuses on three of these categories: polycythemia vera, essential thrombocythemia, and primary myelofibrosis. A number of important questions regarding the diagnosis, prognosis, and treatment of these diseases have arisen following the discovery of the JAK2 V617F mutation in the majority of patients with bcr/abl-negative MPNs. This book comprises evidence-based reviews and expert consensus results. It offers comprehensive coverage of relevant laboratory and clinical advances and places great emphasis on the practical issues that challenge physicians in their daily practice. The main topics considered thus include contemporary diagnostic approaches, the value and limitations of mutation screening for diagnostic and prognostic purposes, risk stratification in terms of both survival and other disease complications such as leukemic transformation and thrombosis, and modern therapeutic strategies, including conventional drugs, allogeneic stem cell transplantation, and experimental drugs still under study. The reader will find Critical Concepts and Management Recommendations in Myeloproliferative Neoplasms to be an invaluable and up-to-date source of information from leading authorities in the field. 240 pp. Englisch. Seller Inventory # 9783642249884

More information about this seller | Contact this seller

Buy New
US$ 211.84
Convert currency

Add to Basket

Shipping: US$ 33.36
From Germany to U.S.A.
Destination, rates & speeds

5.

Published by Springer-Verlag GmbH (2012)
ISBN 10: 3642249884 ISBN 13: 9783642249884
New Hardcover Quantity Available: 1
Seller:
Rating
[?]

Book Description Springer-Verlag GmbH, 2012. Condition: New. Seller Inventory # L9783642249884

More information about this seller | Contact this seller

Buy New
US$ 211.84
Convert currency

Add to Basket

Shipping: US$ 4.29
From Germany to U.S.A.
Destination, rates & speeds

6.

Tiziano Barbui
Published by Springer-Verlag Gmbh Feb 2012 (2012)
ISBN 10: 3642249884 ISBN 13: 9783642249884
New Quantity Available: 1
Seller:
Rating
[?]

Book Description Springer-Verlag Gmbh Feb 2012, 2012. Buch. Condition: Neu. Neuware - Myeloproliferative neoplasms (MPNs) are clonal stem cell diseases that, under the World Health Organization classification, are subcategorized into eight clinicopathologic entities. The current book focuses on three of these categories: polycythemia vera, essential thrombocythemia, and primary myelofibrosis. A number of important questions regarding the diagnosis, prognosis, and treatment of these diseases have arisen following the discovery of the JAK2 V617F mutation in the majority of patients with bcr/abl-negative MPNs. This book comprises evidence-based reviews and expert consensus results. It offers comprehensive coverage of relevant laboratory and clinical advances and places great emphasis on the practical issues that challenge physicians in their daily practice. The main topics considered thus include contemporary diagnostic approaches, the value and limitations of mutation screening for diagnostic and prognostic purposes, risk stratification in terms of both survival and other disease complications such as leukemic transformation and thrombosis, and modern therapeutic strategies, including conventional drugs, allogeneic stem cell transplantation, and experimental drugs still under study. The reader will find Critical Concepts and Management Recommendations in Myeloproliferative Neoplasms to be an invaluable and up-to-date source of information from leading authorities in the field. 240 pp. Englisch. Seller Inventory # 9783642249884

More information about this seller | Contact this seller

Buy New
US$ 211.84
Convert currency

Add to Basket

Shipping: US$ 13.57
From Germany to U.S.A.
Destination, rates & speeds

7.

Tiziano Barbui
Published by Springer-Verlag Gmbh Feb 2012 (2012)
ISBN 10: 3642249884 ISBN 13: 9783642249884
New Quantity Available: 1
Seller:
BuchWeltWeit Inh. Ludwig Meier e.K.
(Bergisch Gladbach, Germany)
Rating
[?]

Book Description Springer-Verlag Gmbh Feb 2012, 2012. Buch. Condition: Neu. Neuware - Myeloproliferative neoplasms (MPNs) are clonal stem cell diseases that, under the World Health Organization classification, are subcategorized into eight clinicopathologic entities. The current book focuses on three of these categories: polycythemia vera, essential thrombocythemia, and primary myelofibrosis. A number of important questions regarding the diagnosis, prognosis, and treatment of these diseases have arisen following the discovery of the JAK2 V617F mutation in the majority of patients with bcr/abl-negative MPNs. This book comprises evidence-based reviews and expert consensus results. It offers comprehensive coverage of relevant laboratory and clinical advances and places great emphasis on the practical issues that challenge physicians in their daily practice. The main topics considered thus include contemporary diagnostic approaches, the value and limitations of mutation screening for diagnostic and prognostic purposes, risk stratification in terms of both survival and other disease complications such as leukemic transformation and thrombosis, and modern therapeutic strategies, including conventional drugs, allogeneic stem cell transplantation, and experimental drugs still under study. The reader will find Critical Concepts and Management Recommendations in Myeloproliferative Neoplasms to be an invaluable and up-to-date source of information from leading authorities in the field. 240 pp. Englisch. Seller Inventory # 9783642249884

More information about this seller | Contact this seller

Buy New
US$ 211.84
Convert currency

Add to Basket

Shipping: US$ 19.37
From Germany to U.S.A.
Destination, rates & speeds

8.

Tiziano Barbui
Published by Springer-Verlag Gmbh Feb 2012 (2012)
ISBN 10: 3642249884 ISBN 13: 9783642249884
New Quantity Available: 1
Seller:
Rheinberg-Buch
(Bergisch Gladbach, Germany)
Rating
[?]

Book Description Springer-Verlag Gmbh Feb 2012, 2012. Buch. Condition: Neu. Neuware - Myeloproliferative neoplasms (MPNs) are clonal stem cell diseases that, under the World Health Organization classification, are subcategorized into eight clinicopathologic entities. The current book focuses on three of these categories: polycythemia vera, essential thrombocythemia, and primary myelofibrosis. A number of important questions regarding the diagnosis, prognosis, and treatment of these diseases have arisen following the discovery of the JAK2 V617F mutation in the majority of patients with bcr/abl-negative MPNs. This book comprises evidence-based reviews and expert consensus results. It offers comprehensive coverage of relevant laboratory and clinical advances and places great emphasis on the practical issues that challenge physicians in their daily practice. The main topics considered thus include contemporary diagnostic approaches, the value and limitations of mutation screening for diagnostic and prognostic purposes, risk stratification in terms of both survival and other disease complications such as leukemic transformation and thrombosis, and modern therapeutic strategies, including conventional drugs, allogeneic stem cell transplantation, and experimental drugs still under study. The reader will find Critical Concepts and Management Recommendations in Myeloproliferative Neoplasms to be an invaluable and up-to-date source of information from leading authorities in the field. 240 pp. Englisch. Seller Inventory # 9783642249884

More information about this seller | Contact this seller

Buy New
US$ 211.84
Convert currency

Add to Basket

Shipping: US$ 19.37
From Germany to U.S.A.
Destination, rates & speeds

9.

Barbui, Tiziano (EDT)/ Tefferi, Ayalew (EDT)
Published by Springer 2012-02-03 (2012)
ISBN 10: 3642249884 ISBN 13: 9783642249884
New Quantity Available: 5
Seller:
Chiron Media
(Wallingford, United Kingdom)
Rating
[?]

Book Description Springer 2012-02-03, 2012. Condition: New. Brand new book, sourced directly from publisher. Dispatch time is 3-4 working days from our warehouse. Book will be sent in robust, secure packaging to ensure it reaches you securely. Seller Inventory # NU-BNT-00961119

More information about this seller | Contact this seller

Buy New
US$ 213.87
Convert currency

Add to Basket

Shipping: US$ 37.77
From United Kingdom to U.S.A.
Destination, rates & speeds

10.

Barbui, Tiziano (Editor)/ Tefferi, Ayalew (Editor)
Published by Springer Verlag (2012)
ISBN 10: 3642249884 ISBN 13: 9783642249884
New Hardcover Quantity Available: 2
Seller:
Revaluation Books
(Exeter, United Kingdom)
Rating
[?]

Book Description Springer Verlag, 2012. Hardcover. Condition: Brand New. 2012 edition. 248 pages. 10.24x7.24x0.63 inches. In Stock. Seller Inventory # __3642249884

More information about this seller | Contact this seller

Buy New
US$ 225.57
Convert currency

Add to Basket

Shipping: US$ 9.44
From United Kingdom to U.S.A.
Destination, rates & speeds

There are 8 more copies of this book

View all search results for this book